Department of Internal Medicine, Cochin Hospital, National Referral Center for Rare Systemic Autoimmune Diseases, Paris University, Paris, France.
Department of Medicine and Surgery, Università degli Studi di Milano-Bicocca, Milano/Monza, Italy.
Rheumatology (Oxford). 2021 Sep 1;60(9):4355-4360. doi: 10.1093/rheumatology/keaa805.
Only a third of patients with eosinophilic granulomatosis with polyangiitis (EGPA) are ANCA-positive, mainly directed against MPO. ANCA directed against PR3 are rarely found in EGPA. We aimed to examine the significance of PR3-ANCA in EGPA.
We set up a retrospective European multicentre cohort including 845 patients. Baseline characteristics and outcomes were analysed and compared according to ANCA status.
ANCA status was available for 734 patients: 508 (69.2%) ANCA-negative, 210 (28.6%) MPO-ANCA and 16 (2.2%) PR3-ANCA. At baseline, PR3-ANCA patients, compared with those with MPO-ANCA and ANCA-negative, less frequently had active asthma (69% vs 91% and 93%, P = 0.003, respectively) and peripheral neuropathy (31% vs 71% and 47%, P < 0.0001), more frequently had cutaneous manifestations (63% vs 38% and 34%, P = 0.03) and pulmonary nodules (25% vs 10% and 8%, P = 0.046), and lower median eosinophil count (1450 vs 5400 and 3224/mm3, P < 0.0001). Vasculitis relapse-free survival was shorter for PR3-ANCA (hazard ratio 6.05, P = 0.005) and MPO-ANCA patients (hazard ratio 1.88, P = 0.0002) compared with ANCA-negative patients.
PR3-ANCA EGPA patients differ from those with MPO-ANCA and negative ANCA, and share clinical features with granulomatosis with polyangiitis. This suggests that PR3-ANCA EGPA could be a particular form of PR3-ANCA-associated vasculitis.
仅有三分之一的嗜酸性肉芽肿性多血管炎(EGPA)患者的抗中性粒细胞胞质抗体(ANCA)阳性,主要针对髓过氧化物酶(MPO)。在 EGPA 中很少发现针对蛋白酶 3(PR3)的 ANCA。我们旨在研究 PR3-ANCA 在 EGPA 中的意义。
我们建立了一个回顾性的欧洲多中心队列,包括 845 名患者。根据 ANCA 状态分析和比较了基线特征和结局。
845 名患者中有 734 名患者的 ANCA 状态可查:508 名(69.2%)为 ANCA 阴性,210 名(28.6%)为 MPO-ANCA,16 名(2.2%)为 PR3-ANCA。在基线时,与 MPO-ANCA 和 ANCA 阴性患者相比,PR3-ANCA 患者较少有活动性哮喘(69%比 91%和 93%,P=0.003)和周围神经病(31%比 71%和 47%,P<0.0001),更常见皮肤表现(63%比 38%和 34%,P=0.03)和肺结节(25%比 10%和 8%,P=0.046),且中位嗜酸性粒细胞计数较低(1450 比 5400 和 3224/mm3,P<0.0001)。与 ANCA 阴性患者相比,PR3-ANCA(风险比 6.05,P=0.005)和 MPO-ANCA 患者(风险比 1.88,P=0.0002)的血管炎无复发生存时间更短。
与 MPO-ANCA 和阴性 ANCA 患者相比,PR3-ANCA EGPA 患者存在差异,与肉芽肿性多血管炎具有相似的临床特征。这表明 PR3-ANCA EGPA 可能是 PR3-ANCA 相关血管炎的一种特殊形式。